|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/22 | |
| A61K 31/198 | |||
| A61K 45/06 | |||
| C07C 229/00 |
| (11) | Patento numeris | 2234963 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08866933.8 |
| Europos patento paraiškos padavimo data | 2008-12-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-10-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/014080 |
| Data | 2008-12-26 |
| (87) | Numeris | WO 2009/085306 |
| Data | 2009-07-09 |
| (30) | Numeris | Data | Šalis |
| 9457 | 2007-12-28 | US |
| (72) |
HSU, Ann, US
KOU, Jim, H., US
ALANI, Laman, Lynn, US
|
| (73) |
Impax Laboratories, LLC,
30831 Huntwood Avenue, Hayward, CA 94544,
US
|
| (54) | CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF |
| CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF |